TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

United Therapeutics Corporation (NASDAQ:UTHR) Investor Investigation Announced

  • If you purchased shares of United Therapeutics Corporation (NASDAQ:UTHR) and currently hold any of those NASDAQ:UTHR shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
United Therapeutics Corporation
Security
NASDAQ: UTHR

Summary

November 9, 2016 (Shareholders Foundation) - An investigation on behalf of investors in shares of United Therapeutics Corporation (NASDAQ:UTHR) was announced over potential breaches of fiduciary duties by certain officers and directors at United Therapeutics.

The investigation by a law firm concerns whether certain United Therapeutics officers and directors breached their fiduciary duties.

United Therapeutics Corporation reported that its annual Total Revenue rose from over $1.28 billion in 2014 to over $1.46 billion in 2015 and that its Net Income increased from $340.07 million in 2014 to $651.64 million in 2015.

Shares of United Therapeutics Corporation (NASDAQ:UTHR) declined from as high as $188.15 per share in June 2015 to as low as $98.33 per share in June 27, 2016.

On November 9, 2016, NASDAQ:UTHR shares closed at $129.98 per share.

Start Monitoring Your Investments